Chan Henry Lee
SVP, General Counsel · 5 filings · Latest: Jul 22, 2026
BeOne Medicines Ltd.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ONC | Chan Henry Lee | SVP, General Counsel | Jul 22, 2026 | Sale | $325.00 | 1,669 | $542.4K | 0 | |
ONC | Chan Henry Lee | SVP, General Counsel | Jul 22, 2026 | Option Exercise | $191.58 | 1,669 | $319.7K | 1,669 | |
ONC | Chan Henry Lee | SVP, General Counsel | Jun 8, 2026 | Sale | $270.42 | 871 | $235.5K | 0 | |
ONC | Chan Henry Lee | SVP, General Counsel | May 13, 2026 | Sale | $310.72 | 332 | $103.2K | 0 | |
ONC | Chan Henry Lee | SVP, General Counsel | May 13, 2026 | Option Exercise | $191.56 | 332 | $63.6K | 332 | |
ONC | Chan Henry Lee | SVP, General Counsel | Mar 11, 2026 | Sale | $300.00 | 341 | $102.3K | 0 | |
ONC | Chan Henry Lee | SVP, General Counsel | Mar 11, 2026 | Option Exercise | $191.64 | 341 | $65.3K | 341 |